A Narrative Review on the Application of High-intensity Focused Ultrasound for the Treatment of Occlusive and Thrombotic Arterial Disease

Overview

Journal JVS Vasc Sci

Specialty Cardiology & Vascular Diseases

Date 2022 Oct 24

PMID 36276806

Authors

Anand Brahmandam

Shin Mei Chan

Alan Dardik

Naiem Nassiri

Edouard Aboian

Affiliations

Soon will be listed here.

Abstract

Objectives: High-intensity focused ultrasound (HIFU) is a noninvasive therapeutic modality with a variety of applications. It is approved for the treatment of essential tremors, ablation of prostate, hepatic, breast, and uterine tumors. Although not approved for use in the treatment of atherosclerotic arterial disease, there is a growing body of evidence investigating applications of HIFU. Currently, percutaneous endovascular techniques are predominant for the treatment of arterial pathology; however, there are no endovascular techniques of HIFU available. This study aims to review the state of current evidence for the application of HIFU in atherosclerotic arterial disease.

Methods: All English-language articles evaluating the effect of HIFU on arterial occlusive and thrombotic disease until 2021 were reviewed. Both preclinical and human clinical studies were included. Study parameters such as animal or clinical model and outcomes were reviewed. In addition, details pertaining to settings on the HIFU device used were also reviewed.

Results: In preclinical models, atherosclerotic plaque progression was inhibited by HIFU, through decreases in oxidized low-density lipoprotein cholesterol and increases in macrophage apoptosis. Additionally, HIFU promotes angiogenesis in hindlimb ischemic models by the upregulation of angiogenic and antiapoptotic factors, with increased angiogenesis at higher line densities of HIFU. HIFU also promotes thrombolysis and conversely induces platelet activation at low frequencies and higher intensities. Various clinical studies have attempted to translate some of these properties and demonstrated positive clinical outcomes for arterial recanalization after thrombotic stroke, decreased atherosclerotic plaque burden in carotid arteries, increase in tissue perfusion and a decrease in diameter stenosis in patients with atherosclerotic arterial disease.

Conclusions: In current preclinical and clinical data, the safety and efficacy of HIFU shows great promise in the treatment of atherosclerotic arterial disease. Future focused studies are warranted to guide the refinement of HIFU settings for more widespread adoption of this technology.

Citing Articles

Numerical simulation study on opening blood-brain barrier by ultrasonic cavitation.

Lei W, Chang S, Tian F, Zou X, Hu J, Qian S Ultrason Sonochem. 2024; 109:107005.

PMID: 39098097 PMC: 11345312. DOI: 10.1016/j.ultsonch.2024.107005.

References

Holfeld J, Tepekoylu C, Blunder S, Lobenwein D, Kirchmair E, Dietl M . Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation. PLoS One. 2014; 9(8):e103982. PMC: 4122398. DOI: 10.1371/journal.pone.0103982. View

Dick F, Diehm N, Galimanis A, Husmann M, Schmidli J, Baumgartner I . Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg. 2007; 45(4):751-61. DOI: 10.1016/j.jvs.2006.12.022. View

Brodmann M, Werner M, Brinton T, Illindala U, Lansky A, Jaff M . Safety and Performance of Lithoplasty for Treatment of Calcified Peripheral Artery Lesions. J Am Coll Cardiol. 2017; 70(7):908-910. DOI: 10.1016/j.jacc.2017.06.022. View

Zhang Y, Dong H, Xu Y, Shi R, Gu J, Lang H . External ultrasound for carotid atherosclerotic plaque treatment. J Ultrasound Med. 2015; 34(3):451-9. DOI: 10.7863/ultra.34.3.451. View

Piazza G, Hohlfelder B, Jaff M, Ouriel K, Engelhardt T, Sterling K . A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv. 2015; 8(10):1382-1392. DOI: 10.1016/j.jcin.2015.04.020. View

Barreto A, Alexandrov A, Shen L, Sisson A, Bursaw A, Sahota P . CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke. Stroke. 2013; 44(12):3376-81. DOI: 10.1161/STROKEAHA.113.002713. View

Conte M, Pomposelli F, Clair D, Geraghty P, McKinsey J, Mills J . Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015; 61(3 Suppl):2S-41S. DOI: 10.1016/j.jvs.2014.12.009. View

Chater B, Williams A . Platelet aggregation induced in vitro by therapeutic ultrasound. Thromb Haemost. 1977; 38(3):640-51. View

Secemsky E, Schermerhorn M, Carroll B, Kennedy K, Shen C, Valsdottir L . Readmissions After Revascularization Procedures for Peripheral Arterial Disease: A Nationwide Cohort Study. Ann Intern Med. 2017; 168(2):93-99. DOI: 10.7326/M17-1058. View

10.

Barlinn K, Tsivgoulis G, Barreto A, Alleman J, Molina C, Mikulik R . Outcomes following sonothrombolysis in severe acute ischemic stroke: subgroup analysis of the CLOTBUST trial. Int J Stroke. 2014; 9(8):1006-10. PMC: 4227933. DOI: 10.1111/ijs.12340. View

11.

Steffen W, Cumberland D, Gaines P, Luo H, Nita H, Maurer G . Catheter-delivered high intensity, low frequency ultrasound induces vasodilation in vivo. Eur Heart J. 1994; 15(3):369-76. DOI: 10.1093/oxfordjournals.eurheartj.a060505. View

12.

Rubiera M, Ribo M, Delgado-Mederos R, Santamarina E, Maisterra O, Delgado P . Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis?. Ultrasound Med Biol. 2008; 34(10):1573-7. DOI: 10.1016/j.ultrasmedbio.2008.02.011. View

13.

Lu Z, Li R, Zhou H, Huang J, Su Z, Qi J . Therapeutic ultrasound reverses peripheral ischemia in type 2 diabetic mice through PI3K-Akt-eNOS pathway. Am J Transl Res. 2016; 8(9):3666-3677. PMC: 5040667. View

14.

Brodmann M, Werner M, Holden A, Tepe G, Scheinert D, Schwindt A . Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. Catheter Cardiovasc Interv. 2018; 93(2):335-342. DOI: 10.1002/ccd.27943. View

15.

Tepekoylu C, Wang F, Kozaryn R, Albrecht-Schgoer K, Theurl M, Schaden W . Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. J Thorac Cardiovasc Surg. 2013; 146(4):971-8. DOI: 10.1016/j.jtcvs.2013.01.017. View

16.

Serizawa F, Ito K, Kawamura K, Tsuchida K, Hamada Y, Zukeran T . Extracorporeal shock wave therapy improves the walking ability of patients with peripheral artery disease and intermittent claudication. Circ J. 2012; 76(6):1486-93. DOI: 10.1253/circj.cj-11-1216. View

17.

Ciccone M, Notarnicola A, Scicchitano P, Sassara M, Carbonara S, Maiorano M . Shockwave therapy in patients with peripheral artery disease. Adv Ther. 2012; 29(8):698-707. DOI: 10.1007/s12325-012-0038-4. View

18.

Chen H, Kreider W, Brayman A, Bailey M, Matula T . Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett. 2011; 106(3):034301. PMC: 3087441. DOI: 10.1103/PhysRevLett.106.034301. View

19.

Damianou C, Hadjisavvas V, Mylonas N, Couppis A, Ioannides K . MRI-guided sonothrombolysis of rabbit carotid artery. J Stroke Cerebrovasc Dis. 2013; 23(2):e113-21. DOI: 10.1016/j.jstrokecerebrovasdis.2013.09.005. View

20.

Yao J, Zhao X, Tan F, Cao X, Guo S, Li X . Early modulation of macrophage ROS-PPARγ-NF-κB signalling by sonodynamic therapy attenuates neointimal hyperplasia in rabbits. Sci Rep. 2020; 10(1):11638. PMC: 7363872. DOI: 10.1038/s41598-020-68543-9. View